WNT5A and prostate carcinoma: In the previous study, increased Wnt5A, β-catenin and VEGF-A were found in non-small-cell lung cancer (NSCLC) [56], and Wnt5A expression was correlated to expression of VEGF, Ki67, androgen receptor in prostate cancer [57].